Science Sparks @ ACTREC
.
14th April 2025Publications
- 1. Mahaddalkar T, Banerjee A, Ketkar M, Thorat R, Gardi N, Dutt S (2025). Aurora Kinase A and B inhibition abrogates 'Neosis', a non-mitotic cell division of GBM residual cells and prevents GBM recurrence. Oncogene.
- 2. More A, Parikh P, Kamtalwar S, Pagdhune A (2025). A case series of Pseudohyperkalemia: A diagnostic dilemma in cancer patients with reactive thrombocytosis. Cureus. 17(4):e81851
- 3. Dholam KP, Somani P, Gurav S, Dugad J, Kharade P, Rane PP, Singh GP (2025). Longitudinal assessment of trismus in patients with advanced stage oral and oropharyngeal cancer. Journal of Prosthetic Dentistry.
- 4. Mukhare R, Gandhi KA, Kadam A, Raja A, Singh A, Madhav M, Chaubal R, Pandey S, Gupta S (2025). Integration of organoids with CRISPR screens: A narrative review. Biology of the Cell. 117(4):e70006.
- 5. Saravanan L, Mahale A, Gota V, Khandelia P, Kulkarni OP (2025). Necrostatin-1 attenuates oral squamous cell carcinoma by modulating tumour immune response in mice. Fundamental and Clinical Pharmacology. 39(3):e70008.
- 6.Sandhbor P, John G, Bhat S, Goda JS (2025). Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases. Asian Journal of Pharmaceutical Sciences. 20(2):101021.
Video of the Week
Management of Classical Hodgkin lymphoma
Upcoming Events
May 26-27, 2025
At Toronto, Canada
May 15-18, 2025
At ACTREC, Tata Memorial Centre, Kharghar , Navi Mumbai
Do You Know?
In 2016, Atezolizumab, the first of an emerging class of inhibitors of PD-L1, was approved by the FDA for the treatment of urothelial carcinoma.
Cancer News
MedicalXpress, 10/04/2025
The research showed that MOv18 IgE works in a unique way, by reversing the suppression of the immune system imposed by the tumor, through activation of different groups of immune cells against the cancer...
EurekAlert, 10/04/2025
Scientists discovered that a structure in the brainstem, a part of the brain that controls vital functions such as breathing and heart rate, acts as a sensor for inflammatory signals in the bloodstream, particularly a molecule called interleukin-6 (IL-6), which is elevated in cancer cachexia...
PharmaTimes, 10/04/2025
Cancer Research scientists have developed a new cell-based model of lung squamous cell carcinoma (LUSC), a type of lung cancer, which has the potential to develop more effective treatments for the disease as well as other cancers...
© 2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)